DEXCOM INC (DXCM) Forecast, Price Target & Analyst Ratings

NASDAQ:DXCMUS2521311074

Current stock price

63.11 USD
-0.1 (-0.16%)
At close:
63.11 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DEXCOM INC (DXCM).

Forecast Snapshot

Consensus Price Target

Price Target
$88.60
+ 40.39% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 30, 2026
Period
Q1 / 2026
EPS Estimate
$0.48
Revenue Estimate
1.198B

ChartMill Buy Consensus

Rating
84.86%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$88.60
Upside
+ 40.39%
From current price of $63.11 to mean target of $88.60, Based on 37 analyst forecasts
Low
$68.68
Median
$86.70
High
$117.60

Price Target Revisions

1 Month
0.30%
3 Months
0.07%

Price Target Summary

37 Wall Street analysts provided a forecast for the next 12 months for DXCM. The average price target is 88.6 USD. This implies a price increase of 40.39% is expected in the next year compared to the current price of 63.11.
The average price target has been revised upward by 0.07% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

DXCM Current Analyst RatingDXCM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15

Analyst Ratings History

DXCM Historical Analyst RatingsDXCM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30

Analyst Ratings Consensus

ChartMill Buy Consensus
84.86%
DXCM was analyzed by 37 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about DXCM.
In the previous month the buy percentage consensus was at a similar level.
DXCM was analyzed by 37 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-11CitigroupMaintains Buy -> Buy
2026-03-09BTIGReiterate Buy -> Buy
2026-02-25BTIGReiterate Buy -> Buy
2026-02-17Truist SecuritiesReiterate Buy -> Buy
2026-02-13MizuhoMaintains Outperform -> Outperform
2026-02-13BTIGReiterate Buy -> Buy
2026-02-13BarclaysMaintains Underweight -> Underweight
2026-02-13Wells FargoMaintains Overweight -> Overweight
2026-02-13Canaccord GenuityMaintains Buy -> Buy
2026-01-12BarclaysDowngrade Equal-Weight -> Underweight
2026-01-09BernsteinMaintains Outperform -> Outperform
2025-12-17MizuhoMaintains Outperform -> Outperform
2025-12-11CitigroupMaintains Buy -> Buy
2025-12-02Morgan StanleyUpgrade Equal-Weight -> Overweight
2025-11-25Evercore ISI GroupInitiate In-Line
2025-11-10Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2025-11-07Argus ResearchMaintains Buy -> Buy
2025-11-03UBSMaintains Buy -> Buy
2025-11-03BarclaysMaintains Equal-Weight -> Equal-Weight
2025-11-03Truist SecuritiesReiterate Buy -> Buy
2025-10-31TD CowenMaintains Buy -> Buy
2025-10-31BTIGMaintains Buy -> Buy
2025-10-31RBC CapitalMaintains Outperform -> Outperform
2025-10-31Wells FargoMaintains Overweight -> Overweight
2025-10-31JP MorganMaintains Neutral -> Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 30, 2026
Period
Q1 / 2026
EPS Estimate
$0.48
Revenue Estimate
1.198B
Revenue Q2Q
15.64%
EPS Q2Q
49.54%
Number of Analysts
27

Next Earnings Revisions

Revenue (1 Month)
-0.08%
Revenue (3 Months)
-0.66%
EPS (1 Month)
0.17%
EPS (3 Months)
-0.14%

Next Earnings Summary

DXCM is expected to report earnings on 4/30/2026. The consensus EPS estimate for the next earnings is 0.48 USD and the consensus revenue estimate is 1.20B USD.
The next earnings revenue estimate has been revised downward by 0.66% in the past 3 months.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
DXCM revenue by date.DXCM revenue by date.
3.622B
24.49%
4.033B
11.34%
4.662B
15.60%
5.336B
14.46%
5.993B
12.31%
6.725B
12.21%
7.565B
12.49%
8.329B
10.10%
8.494B
1.98%
9.469B
11.48%
10.346B
9.26%
EBITDA
YoY % growth
DXCM ebitda by date.DXCM ebitda by date.
800.3M
42.66%
871.2M
8.86%
1.256B
44.21%
1.612B
28.30%
1.914B
18.73%
2.22B
15.99%
2.754B
24.05%
3.007B
9.19%
N/AN/AN/A
EBIT
YoY % growth
DXCM ebit by date.DXCM ebit by date.
614.3M
51.64%
653.5M
6.38%
1.005B
53.73%
1.203B
19.75%
1.457B
21.11%
1.741B
19.49%
2.081B
19.53%
2.401B
15.38%
2.56B
6.62%
2.893B
13.01%
3.203B
10.72%
Operating Margin
DXCM operating margin by date.DXCM operating margin by date.
16.96%16.20%21.55%22.54%24.31%25.89%27.51%28.83%30.14%30.55%30.96%
EPS
YoY % growth
DXCM eps by date.DXCM eps by date.
1.51
73.56%
1.65
9.27%
1.86
12.73%
2.54
36.69%
3.04
19.40%
3.63
19.64%
4.32
19.02%
4.97
14.91%
N/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth
0.48
49.54%
0.62
28.30%
0.69
13.12%
0.76
67.99%
0.61
27.36%
0.73
19.11%
0.80
16.28%
0.87
15.70%
0.81
32.22%
0.86
16.80%
0.89
10.59%
0.92
4.96%
Revenue
Q2Q % growth
1.198B
15.64%
1.323B
14.34%
1.37B
13.29%
1.435B
13.93%
1.355B
13.11%
1.477B
11.64%
1.521B
11.02%
1.597B
11.29%
1.603B
18.30%
1.649B
11.65%
1.682B
10.59%
1.707B
6.89%
EBITDA
Q2Q % growth
320.31M
65.36%
395.48M
17.84%
434.04M
1.15%
469.75M
-29.64%
391.37M
22.18%
468.24M
18.40%
503.14M
15.92%
542.8M
15.55%
498.6M
27.40%
534.3M
14.11%
545.41M
8.40%
570.52M
5.11%
EBIT
Q2Q % growth
222.53M
66.44%
292.2M
37.44%
327.62M
35.10%
360.81M
-13.23%
278.58M
25.19%
352.11M
20.50%
382.91M
16.88%
420.1M
16.43%
371.93M
33.51%
395.66M
12.37%
407.06M
6.31%
423.3M
0.76%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

DXCM Yearly Revenue VS EstimatesDXCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
DXCM Yearly EPS VS EstimatesDXCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
24.99%
EPS Next 5 Year
21.71%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
12.38%
Revenue Next 5 Year
11.94%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
32.44%
EBIT Next 5 Year
25.77%

DEXCOM INC / DXCM Forecast FAQ

What do analysts expect the price target to be for DEXCOM INC (DXCM)?

37 analysts have analysed DXCM and the average price target is 88.6 USD. This implies a price increase of 40.39% is expected in the next year compared to the current price of 63.11.

When does DEXCOM INC (DXCM) report earnings?

DEXCOM INC (DXCM) will report earnings on 2026-04-30.

What are the consensus estimates for DXCM stock next earnings?

The consensus EPS estimate for the next earnings of DEXCOM INC (DXCM) is 0.48 USD and the consensus revenue estimate is 1.20B USD.

Can you provide the consensus rating for DEXCOM INC stock?

The consensus rating for DEXCOM INC (DXCM) is 84.8649 / 100 . This indicates that analysts generally have a positive outlook on the stock.